Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome
- PMID: 39917307
- PMCID: PMC11798879
- DOI: 10.3389/fimmu.2025.1517347
Characterization of a WAS splice-site variant in a patient with Wiskott-Aldrich syndrome
Abstract
Wiskott-Aldrich syndrome (WAS) (MIM #301000) is a rare X-linked primary immunodeficiency due to mutations in the WAS gene, characterized by thrombocytopenia with small platelets, eczema, recurrent infections, and an increased incidence of autoimmunity and malignancies. A wide spectrum of mutations has been identified in the WAS gene responsible for a broad variety of clinical phenotypes. By using targeted next-generation sequencing (t-NGS), we identified in a 2-month-old boy with thrombocytopenia and immunological alterations a 4-nucleotide deletion from position +3 to +6 of intron 8 (c.777 + 3_777 + 6delGAGT) of WAS, currently classified on ClinVar as a variant of uncertain significance. The in-vitro characterization of the variant revealed the complete retention of intron 8 in the mature transcript, suggesting a splicing defect due to the loss of a splice donor site at the 5'-end of intron 8. By sequencing the polymerase chain reaction product, we identified a premature stop at codon 269; thus, consequently, no Wiskott-Aldrich syndrome protein (WASp) was detectable in peripheral blood mononuclear cells from the patient. Due to the total absence of a full-length WASp, it is expected that the patient will develop the severe form of the disease, although further monitoring is needed to better define his phenotype.
Keywords: WASP; Wiskott-Aldrich; gene panel; next-generation sequencing (NGS); splice-site mutation.
Copyright © 2025 Toriello, Maritato, De Rosa, Esposito, Damiano, Rosano, Cirillo, Tarallo, Abagnale, Cillo, Romano, Grilli, Comegna, Blasio, Parenti, Surace, Castaldo, Pignata and Giardino.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.
Figures
References
-
- Coppola E, Giardino G, Abate M, Tambaro FP, Bifano D, Toriello E, et al. . Rare solid tumors in a patient with Wiskott–Aldrich syndrome after hematopoietic stem cell transplantation: case report and review of literature. Front Immunol. (2023) 14:1229674. doi: 10.3389/fimmu.2023.1229674 - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
